Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate.

Abstract:

:A 67-year-old woman with iron deficiency anemia required parenteral iron therapy and was treated with intravenous ferric gluconate. She tolerated the first dose, but after the second dose, she developed a tingling feeling all over her body, along with swelling in her hands and feet, and a rash with hives over most of her body. It was thought that she had likely experienced a hypersensitivity reaction to ferric gluconate. The decision was made to continue therapy; however, two modifications were made. The patient was given dexamethasone, diphenhydramine, and ibuprofen 1 hour before administering the third dose, and the infusion time was prolonged by 1 hour. Approximately 45 minutes after the infusion was completed, the patient developed hives on her arms and legs. At the patient's next clinic visit, it was decided that continuation of parenteral iron repletion was necessary, and the decision was made to attempt a challenge with iron sucrose. The patient was given dexamethasone 8 mg to be taken the night before and the morning of treatment. She successfully completed the iron repletion therapy with iron sucrose. Three parenteral iron products are available in the United States: iron dextran, sodium ferric gluconate complex, and iron sucrose. Iron dextran, the oldest of these products, carries the highest risk for hypersensitivity reactions. Available data suggest that either iron sucrose or ferric gluconate can be safely administered to patients with known hypersensitivity to iron dextran. Our patient's experience implies that it may be possible to safely administer iron sucrose to a patient with hypersensitivity to ferric gluconate. This finding has clinical implications and warrants confirmation in a larger population.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Sane R,Baribeault D,Rosenberg CL

doi

10.1592/phco.27.4.613

subject

Has Abstract

pub_date

2007-04-01 00:00:00

pages

613-5

issue

4

eissn

0277-0008

issn

1875-9114

journal_volume

27

pub_type

杂志文章
  • Acute Graft-versus-Host Disease: Emerging Insights and Updates into Detection, Prevention, and Treatment.

    abstract::Acute graft-versus-host disease remains a devastating complication following hematopoietic cell transplantation, resulting in increased morbidity and mortality. Vast research efforts continue to refine or develop new means of prediction, assessment, prevention, and treatment of this syndrome. Recent updates in acute g...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2436

    authors: DiMaggio E

    更新日期:2020-08-01 00:00:00

  • Torsades de pointes associated with fluoroquinolones.

    abstract::Recent attention has been called to the interpretation of studies of antiinfective agents demonstrating effects on the QTc interval. It seems that the effects of many of these agents on the QTc interval are small, but in some patient populations, these drugs may cause morbidity and mortality related to TdP. It would b...

    journal_title:Pharmacotherapy

    pub_type: 评论,杂志文章

    doi:10.1592/phco.22.8.663.33201

    authors: Owens RC Jr,Ambrose PG

    更新日期:2002-05-01 00:00:00

  • Tobramycin pharmacokinetics in children with febrile neutropenia undergoing stem cell transplantation: once-daily versus thrice-daily administration.

    abstract:STUDY OBJECTIVE:To describe the pharmacokinetic disposition of tobramycin in children undergoing stem cell transplantation (SCT) after intravenous administration either every 24 hours or every 8 hours, and to use this information to create initial dosing guidelines for administration every 24 hours in this patient popu...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.24.6.564.34743

    authors: Dupuis LL,Sung L,Taylor T,Abdolell M,Allen U,Doyle J,Taddio A

    更新日期:2004-05-01 00:00:00

  • Neurotoxicity associated with ceftazidime therapy in geriatric patients with renal dysfunction.

    abstract::Ceftazidime, a beta-lactamase-stable, third-generation cephalosporin, is widely used for the treatment of serious gram-negative infections. Neurotoxicity has rarely been associated with the drug; however, two of our patients developed ceftazidime-induced neurotoxicity that produced confusion, disorientation, agitation...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Slaker RA,Danielson B

    更新日期:1991-01-01 00:00:00

  • Twice-daily Trizivir versus Combivir-abacavir in antiretroviral-experienced adults with human immunodeficiency virus-1 infection: a formulation-switch trial.

    abstract:STUDY OBJECTIVE:To establish the clinical equivalence (noninferiority) of one tablet containing abacavir 300 mg-lamivudine 150 mg-zidovudine 300 mg (Trizivir) versus a tablet containing lamivudine 150 mg-zidovudine 300 mg (Combivir) given with one abacavir (ABC) 300-mg tablet, administered twice/day, in antiretroviral-...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1592/phco.23.14.1432.31944

    authors: Fischl MA,Burnside AE Jr,Farthing CE,Thompson MA,Bellos NC,Williams VC,Kauf TL,Wannamaker PG,Shaefer MS,ESS40005 Study Team.

    更新日期:2003-11-01 00:00:00

  • Respiratory tract penetration of quinolone antimicrobials: a case in study.

    abstract::Antimicrobial lung penetration is thought to be predictive of efficacy in the treatment of lower respiratory tract infections. Lung penetration studies are commonly conducted with new antimicrobial agents to elucidate their potential utility in treating such infections. Although some very useful information may emerge...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Ritrovato CA,Deeter RG

    更新日期:1991-01-01 00:00:00

  • Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy.

    abstract:OBJECTIVE:To identify and describe the scope of practice that characterizes the critical care pharmacist and critical care pharmacy services. Specifically, the goals were to define the level of clinical practice and specialized skills characterizing the critical care pharmacist as clinician, educator, researcher, and m...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors:

    更新日期:2000-11-01 00:00:00

  • Antimony excretion in a patient with renal impairment during meglumine antimoniate therapy.

    abstract::Meglumine antimoniate was administered to a patient with visceral leishmaniasis with normal renal function. Soon after the first intramuscular administration of meglumine antimoniate 20 mg/kg, equivalent to 510 mg antimony (Sb), the patient developed septic shock with oliguria. Creatinine clearance decreased to 23 ml/...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.13.1141.35032

    authors: Hantson P,Luyasu S,Haufroid V,Lambert M

    更新日期:2000-09-01 00:00:00

  • Cholesterol and glycemic effects of Niaspan in patients with type 2 diabetes.

    abstract:STUDY OBJECTIVE:To determine the effect of Niaspan--a niacin preparation with both immediate- and extended-release characteristics--on lipid and glycemic control in patients with type 2 diabetes. DESIGN:Retrospective study SETTING:Private-practice endocrinology group. PATIENTS:Thirty-two patients (mean age 60 yrs; 7...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.21.20.1473.34481

    authors: Kane MP,Hamilton RA,Addesse E,Busch RS,Bakst G

    更新日期:2001-12-01 00:00:00

  • Maximizing the benefit of pharmacotherapy in Parkinson's disease.

    abstract::Levodopa is one of the principal agents administered to treat patients with Parkinson's disease (PD). Several pharmacologic strategies can limit its side effects and enhance its activity. Although certain exceptions apply, dosage adjustments and drug changes should be instituted slowly. Levodopa is typically introduce...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.20.2.33s.34632

    authors: Berchou RC

    更新日期:2000-01-01 00:00:00

  • Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.

    abstract::Antimicrobial resistance among gram-positive organisms such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) continues to limit therapeutic options. The oxazolidinones are a synthetic class of agents now commonly relied on for the treatment of serious MRSA and VRE infect...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1491

    authors: Rybak JM,Marx K,Martin CA

    更新日期:2014-11-01 00:00:00

  • Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.

    abstract:STUDY OBJECTIVE:To evaluate the effect of acarbose on glycemic control and glycemic variability, using a continuous glucose-monitoring system, in patients with type 2 diabetes mellitus who were not well controlled on metformin and vildagliptin therapy. DESIGN:Multicenter, randomized, double-blind, placebo-controlled s...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1002/phar.1648

    authors: Derosa G,Franzetti I,Querci F,D'Angelo A,Maffioli P

    更新日期:2015-11-01 00:00:00

  • Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin.

    abstract::Dabigatran, a direct thrombin inhibitor, is an oral anticoagulant indicated for the prevention of stroke in patients with atrial fibrillation (AF) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. Dabigatran, as well as the other new anticoagulants-rivaroxaban, apixaban, and edoxaban...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1698

    authors: Wiggins BS,Northup A,Johnson D,Senfield J

    更新日期:2016-02-01 00:00:00

  • White Paper on Natural Products.

    abstract::The American College of Clinical Pharmacy (ACCP) published an initial white paper on herbal products in 2000. Since then, the global market for natural products has continued to expand, with tens of millions of consumers using such products on an annual basis in the United States alone. However, despite this expansion...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1874

    authors: Gabay M,Smith JA,Chavez ML,Goldwire M,Walker S,Coon SA,Gosser R,Hume AL,Musselman M,Phillips J,Abe AM

    更新日期:2017-01-01 00:00:00

  • Fatal clindamycin-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome.

    abstract::Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a rare, complex, idiosyncratic drug reaction that can be fatal. Systemic symptoms include lymphadenopathy, hepatic failure, and possibly renal failure. The syndrome has been primarily associated with anticonvulsants, whereas antimicrobials are less ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1142

    authors: Miller Quidley A,Bookstaver PB,Gainey AB,Gainey MD

    更新日期:2012-12-01 00:00:00

  • Expanding Opportunities in the Postacute Long-Term Care Setting: Bringing Medication Safety to the Next Level.

    abstract::Skilled nursing facilities and nursing homes are care settings that offer increasing opportunities for pharmacists to take the lead when addressing the new updated Centers for Medicare and Medicaid Services (CMS) requirements coupled with enhanced quality measures reporting. In addition, the complexity of the medicati...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2155

    authors: Brandt NJ,Worz C,Clackum SF

    更新日期:2018-08-01 00:00:00

  • The impact of hyponatremia.

    abstract::Hyponatremia is the most common electrolyte disorder encountered in clinical practice and is associated with significant morbidity and mortality. Clinical consequences of hyponatremia include neurologic dysfunction, decreased mental function, cerebral edema, gait disturbances and falls, osteoporosis, and fractures. Hy...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.31.5.5S

    authors: Patterson JH

    更新日期:2011-05-01 00:00:00

  • A clinical perspective for the management of invasive fungal infections: focus on IDSA guidelines. Infectious Diseases Society of America.

    abstract::Invasive fungal infections, especially candidiasis and aspergillosis, are a major cause of morbidity and mortality. Many controversies surround the management of these infections. A critical overview of the recent Infectious Diseases Society of America practice guidelines is provided, as are comments on both the conun...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.21.12.175s.34506

    authors: Kontoyiannis DP

    更新日期:2001-08-01 00:00:00

  • Decreased antimicrobial resistance after changes in antibiotic use.

    abstract::Vancomycin-resistant enterococci (VRE) and methicillin-oxacillin-resistant Staphylococcus aureus (MRSA) originally predominated in large medical centers; however, these isolates are now common in community hospitals and community clinics. No simple answer is available regarding control of antimicrobial-resistant bacte...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.19.12.129s.31702

    authors: Smith DW

    更新日期:1999-08-01 00:00:00

  • The importance of in-hospital statin therapy for patients with acute coronary syndromes.

    abstract::Starting lipid-lowering therapy in the hospital, especially with statins, has become an important component in the management of patients with acute coronary syndromes (ACS). It improves outcomes and increases patient motivation and long-term adherence. In addition, discontinuation of statin therapy in patients with A...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.23.4.506.32129

    authors: Paradiso-Hardy FL,Gordon WL,Jackevicius CA,Kertland HR,Pearson GJ,Pickering JL,Poirier L,Semchuk BM,Verret L

    更新日期:2003-04-01 00:00:00

  • The impact of first-line antihypertensive drugs on erectile dysfunction.

    abstract::Erectile dysfunction, a problem estimated to affect up to 30 million American men, is associated with a number of systemic illnesses and drugs. Age is not thought to be an independent risk factor for the disorder, but accompanying illnesses and their treatments may contribute to its onset. Newer classes of antihyperte...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.19.8.573.31526

    authors: Barksdale JD,Gardner SF

    更新日期:1999-05-01 00:00:00

  • Association Between Time-in-Therapeutic Tacrolimus Range and Early Rejection After Heart Transplant.

    abstract:BACKGROUND:Historically, there is perceived pressure to achieve therapeutic levels of tacrolimus quickly after heart transplant (HT). We evaluated the association between time within therapeutic tacrolimus range and time to therapeutic trough and rejection in the 30 days following HT. METHODS:This is a single-center r...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2262

    authors: Baker WL,Steiger S,Martin S,Patel N,Radojevic J,Darsaklis K,O'Bara L,Kutzler H,Dougherty J,Feingold A,Hammond J,Fusco D,Gluck JA

    更新日期:2019-05-01 00:00:00

  • Comparing the bispectral index and suppression ratio with burst suppression of the electroencephalogram during pentobarbital infusions in adult intensive care patients.

    abstract:OBJECTIVE:The bispectral index (BIS), a processed variable derived from the raw electroencephalogram (EEG) used to guide sedation in the intensive care unit (ICU), has not been tested during barbiturate therapy for elevated intracranial pressure. We determined the BIS and suppression ratio (SR) values during traditiona...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.23.10.1087.32766

    authors: Riker RR,Fraser GL,Wilkins ML

    更新日期:2003-09-01 00:00:00

  • Potentially inappropriate drug use and health-related quality of life in the elderly.

    abstract:STUDY OBJECTIVE:To investigate the relationship between two widely used, generic health-related quality of life (HRQOL) measures, Short Form-12 (SF-12) and EuroQol's EQ-5D, and potentially inappropriate drug use in an elderly cohort. DESIGN:Longitudinal retrospective cohort study. DATA SOURCE:Medical Expenditure Pane...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.26.6.768

    authors: Franic DM,Jiang JZ

    更新日期:2006-06-01 00:00:00

  • Comparison of two methods for INR determination in a pharmacist-based oral anticoagulation clinic.

    abstract::Warfarin is a commonly used oral anticoagulant that is usually initiated after the definitive diagnosis of a certain thromboembolic disorder or disease. Warfarin therapy will usually be prescribed for 6-12 weeks or more, and some patients may continue therapy throughout life, depending on the type of thromboembolic di...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:

    authors: Yamreudeewong W,Johnson JV,Cassidy TG,Berg JT

    更新日期:1996-11-01 00:00:00

  • Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 Diabetes.

    abstract::The efficacy of the sodium-glucose cotransporter 2 (SGLT2) inhibitors canagliflozin, dapagliflozin, and empagliflozin in reducing hyperglycemia in patients with type 2 diabetes is well documented. In addition, positive effects have been observed with these agents on nonglycemic variables, such as reductions in body we...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1903

    authors: Trujillo JM,Nuffer WA

    更新日期:2017-04-01 00:00:00

  • A pharmacoeconomic model to evaluate antibiotic costs.

    abstract:STUDY OBJECTIVES:To characterize patient sociodemographics and health, describe vancomycin treatment parameters and clinician-rated outcomes, and determine costs associated with treatment including preparation and administration, adverse events, and toxicity. DESIGN:A prospective study to develop a model for costs ass...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Garrelts JC,Horst WD,Silkey B,Gagnon S

    更新日期:1994-07-01 00:00:00

  • Risk Factors for Voriconazole-Associated Hepatotoxicity in Patients in the Intensive Care Unit.

    abstract:STUDY OBJECTIVES:To determine the incidence of hepatotoxicity in critically ill patients who were treated with voriconazole and to identify potential risk factors for voriconazole-associated hepatotoxicity in these patients. DESIGN:Single-center prospective observational study. SETTING:Intensive care unit (ICU) in a ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1779

    authors: Wang Y,Wang T,Xie J,Yang Q,Zheng X,Dong W,Xing J,Wang X,Dong Y

    更新日期:2016-07-01 00:00:00

  • The antioxidant vitamins: impact on atherosclerosis.

    abstract::Atherosclerosis, the great killer of Western society, probably is initiated when the balance of subendothelial lipoproteins and oxidation potential is upset. Oxidation products, especially oxidized low-density lipoprotein, set into motion the cascading of numerous pathways, culminating in the fibrous atherosclerotic p...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Meyers DG,Maloley PA

    更新日期:1993-11-01 00:00:00

  • Clinical pharmacology of rapacuronium bromide, a new short-acting neuromuscular blocking agent.

    abstract::Rapacuronium is a new steroidal, nondepolarizing, neuromuscular blocking agent. It appears to be the least potent of all available nondepolarizing muscle relaxants. Its onset of action resembles that of succinylcholine, and its recovery times are shorter than those of other nondepolarizing agents. The clinical duratio...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.19.15.1118.30572

    authors: Larijani GE,Zafeiridis A,Goldberg ME

    更新日期:1999-10-01 00:00:00